Congress Resource Centre
Global Edition Home
Contact us
Up to the minute coverage from key international congresses
Offering the latest congress news in oncology !
DG Dispatch
your speedy delivery of the latest news and highlights direct from medical congresses ...
keeping you medically current !
DG Dispatches - Oncology
07/02/2009
Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI
07/02/2009
Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI
07/02/2009
90Y Radioembolisation Provides Benefit for Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy: Presented at ESMO-GI
07/02/2009
Everolimus Is an Effective Treatment Option for Patients With Pancreatic Neuroendocrine Tumours: Presented at ESMO-GI
07/01/2009
FDG-PET Can Help Prevent Unnecessary Surgery in Patients With Colorectal Liver Metastases: Presented at ESMO-GI
07/01/2009
Radiofrequency Ablation With Chemotherapy Improves Progression-Free Survival in Unresectable Colorectal Cancer Liver Metastases: Presented at ESMO-GI
06/29/2009
KRAS Status Predicts Survival to Cetuximab Plus FOLFOX6 in Patients With Metastatic CRC: Presented at ESMO-GI
06/29/2009
Survival Prolonged With FOLFOXIRI Compared With FOLFIRI in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI
06/26/2009
Adding Cetuximab to Standard Chemotherapy Improves Response Rates in Patients With Nonresectable Colorectal Liver Metastases: Presented at ESMO-GI
06/26/2009
Bevacizumab Plus Chemotherapy Is Safe, Effective for Older Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI
06/26/2009
Sunitinib Significantly Improves Progression-Free Survival in Patients With Advanced Pancreatic Islet Cell Tumours: Presented at ESMO-GI
06/24/2009
Certain Clinical, Ultrasonographic Characteristics Can Assist in Diagnosing Uveal Melanoma: Presented at COS
06/24/2009
Cladribine Is Safe Overall in Patients With Multiple Sclerosis: Presented at ENS
06/23/2009
Incidence of Febrile Neutropenia After Chemotherapy in Hospitalised Patients Appears Lower Than Expected in Canada: Presented at ICC
06/14/2009
Low-Dose Radioactive Iodine Is Efficacious in Patients With Papillary Thyroid Cancer: Presented at ENDO 09
06/11/2009
New Schedule for Chemotherapy Should Be Standard Treatment for Patients With Early Unfavourable Hodgkin's Lymphoma: Presented at EHA
06/10/2009
Adding Bortezomib to Melphalan/Prednisone or Thalidomide/Prednisone Provides Similar Response Rates in Elders With Multiple Myeloma: Presented at EHA
06/10/2009
Histamine Dihydrochloride/IL-2 Immunotherapy Maintains Improvement in Leukaemia-Free Survival in Acute Myeloid Leukaemia: Presented at EHA
06/09/2009
Suboptimal Response of Imatinib 400 mg in Chronic Myeloid Leukaemia Indicates Need for Early Intervention: Presented at EHA
06/09/2009
Significant Survival Benefit From Adding Oblimersen to Fludarabine-Cyclophosphamide Combination Therapy in Relapsed/Refractory Chronic Lymphocytic Leukaemia: Presented at EHA
06/08/2009
Adding Norethandrolone to Postremission Chemotherapy Improves Outcomes in Elders With de Novo AML: Presented at EHA
06/08/2009
Lenalidomide Plus Dexamethasone Offers Rapid, Effective Treatment for Relapsed or Refractory Multiple Myeloma: Presented at EHA
06/06/2009
Bendamustine Provides Benefit Over Chlorambucil for Patients With Chronic Lymphocytic Leukaemia: Presented at EHA
06/06/2009
In Diffuse, Large B-Cell Non-Hodgkin's Lymphoma, R-CHOP14 Is Similar to R-CHOP21: Presented at ASCO
06/06/2009
Adding Thalidomide to Bortezomib, Melphalan, Prednisone Improves Progression-Free Survival in Elders With Multiple Myeloma: Presented at ASCO
06/05/2009
Concurrent Use of Tamoxifen, Antidepressants Associated With Double Risk of Breast Cancer Relapse: Presented at ASCO
06/05/2009
Curative Surgery May Be Unnecessary for Some Patients With Metastatic Colorectal Cancer: Presented at ASCO
06/05/2009
Ixabepilone Plus Bevacizumab Demonstrates Encouraging Activity Relative to Paclitaxel Plus Bevacizumab for Metastatic Breast Cancer: Presented at ASCO
06/04/2009
Delayed Symptom Progression, Better Tolerability Found With Pegylated Liposomal Doxorubicin Plus Carboplatin for Ovarian Cancer: Presented at ASCO
06/04/2009
Personalised Therapeutic Vaccine Prolongs Progression-Free Survival in Patients With Follicular Lymphoma: Presented at ASCO
All contents Copyright (c) 2002 P\S\L Consulting Group Inc. All rights reserved.